5th Annual Cell Engager Summit
Evvnt Promotion / evvnt
Archivio
24.04.2023 - 27.04.2023 Hilton Boston Logan Airport, One Hotel Drive, 02128 Boston, Massachusetts, USA
Time: 08:00 - 17:00
Temi della conferenza
The TCE pipeline is ever-growing and there are multiple different formats, engagers and costimulatory being studied in over 90 trials, with over a hundred projects in the preclinical stage. To treat hematological malignancies, the majority of pharmaceutical and biotech companies are focusing on lymphocyte-restricted tumor-associated antigens such as CD19, CD20, BCMA, CD33, and CD123.
The TCE pipeline is ever-growing and there are multiple different formats, engagers and costimulatory being studied in over 90 trials, with over a hundred projects in the preclinical stage. To treat hematological malignancies, the majority of pharmaceutical and biotech companies are focusing on lymphocyte-restricted tumor-associated antigens such as CD19, CD20, BCMA, CD33, and CD123.
Scientific organizer
Hanson Wade
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/1508305-3?pid=4832
Speakers: Amer Najjar, Assistant Professor, Department of Pediatrics - Research, Division of Pediatrics, MD Anderson Cancer Center, and more.
Brochure: https://go.evvnt.com/1508305-3?pid=4832
Speakers: Amer Najjar, Assistant Professor, Department of Pediatrics - Research, Division of Pediatrics, MD Anderson Cancer Center, and more.
Informazioni ed Iscrizioni:
https://go.evvnt.com/1508305-2?pid=4832
Mr. Min Ratcliffe
Medicina General
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
